Remove Arrhythmia Remove Pericarditis Remove Public Health
article thumbnail

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Food & Drug Administration ( FDA ).

article thumbnail

Vaccine myocarditis update from Korea

Dr. Anish Koka

While US public health authorities have been convinced from the very beginning about how safe and effective the new vaccines are, researchers in other countries with far smaller budgets have been testing that theory. But these rates are in line with a few other large datasets which lends credibility to the estimates.

article thumbnail

A COVID19 vaccine exemption letter

Dr. Anish Koka

4 An accompanying editorial 5 notes “Data from COVID-Heart provide reassuring evidence that myocarditis, once predicted to be an emerging public health crisis attributable to COVID-19, is relatively uncommon even among hospitalized patients and is less virulent than predicted during the early days of the pandemic.